WHOLE-VIRION CULTURE INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE GENOTYPE SAT-1/X Russian patent published in 2025 - IPC A61K39/135 

FIELD: veterinary virology; biotechnology.

SUBSTANCE: invention refers to veterinary virology and biotechnology, namely to development of a foot-and-mouth disease genotype SAT-1/X culture whole-virion inactivated emulsion vaccine. Foot-and-mouth disease genotype SAT-1/X, culture-based whole virion inactivated emulsion, embodying the invention, is intended for use in agriculture, specifically in veterinary virology and biotechnology; possibility of realizing present is confirmed; vaccine prepared of the strain SAT-1/Nigeria/2015 of genotype SAT-1/X of foot-and-mouth disease virus according to the presented invention possesses high immunogenic activity and is capable to provide effective protection of susceptible animals against foot-and-mouth disease virus of genotype SAT-1/X. Foot-and-mouth disease genotype SAT-1/X, whole-virion culture inactivated emulsion vaccine is prepared with using Coralvac RZ 506 oil adjuvant.

EFFECT: invention extends the range of foot-and-mouth disease inactivated culture whole virion emulsion vaccines for protection of animals against isolates and strains of foot-and-mouth disease virus genotype SAT-1/X.

2 cl, 3 dwg, 7 tbl, 15 ex